Stereotactic Body Radiation Therapy (Stereotactic Ablative Radiotherapy) for Stage I Non-Small Cell Lung Cancer - Updates of Radiobiology, Techniques, and Clinical Outcomes

被引：0

作者：

Hadziahmetovic, Mersiha ^{[1
]}

Loo, Billy W. ^{[2
]}

Timmerman, Robert D. ^{[3
]}

Mayr, Nina A. ^{[1
]}

Wang, Jian Z. ^{[1
]}

Huang, Zhibin ^{[1
]}

Grecula, John C. ^{[1
]}

Lo, Simon S. ^{[1
]}

机构：

[1] Ohio State Univ, Arthur G James Canc Hosp, Dept Radiat Oncol, Columbus, OH 43210 USA

[2] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA

[3] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA

来源：

DISCOVERY MEDICINE | 2010年 / 9卷 / 48期

关键词：

PHASE-II; TOXICITY;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), has emerged as one of the standard treatment options for stage I non-small cell lung cancer (NSCLC), mainly in medically inoperable patients. Its use has also been explored in operable patients. A large body of experience, either from retrospective studies or clinical trials, has been accumulated over the years and more is known about the radiobiology, cancer biology, technical aspects, clinical outcomes, and toxicities of SBRT. This article provides updates of these aspects of SBRT for stage I NSCLC.

引用

页码：411 / 416

页数：6

共 50 条

[1] Utility of stereotactic ablative radiotherapy/stereotactic body radiation therapy in the setting of oligometastatic non-small cell lung cancer
Song, Andrew
Lu, Bo
[J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 657 - 660
[2] STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCER
Beltramo, G.
Bergantin, A.
Martinotti, A.
Bonfanti, P.
Bianchi, L. C.
[J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S570 - S571
[3] Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
Aridgides, Paul
Bogart, Jeffrey
[J]. THORACIC SURGERY CLINICS, 2016, 26 (03) : 261 - +
[4] Safety of stereotactic ablative body radiation for ultracentral stage I non-small cell lung cancer
Wu, Abraham J. G-Ching
[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S135 - S138
[5] Stereotactic body radiotherapy for stage I non-small cell lung cancer
Martel-Lafay, I.
[J]. ONCOLOGIE, 2012, 14 (05) : 282 - 288
[6] Stereotactic body radiotherapy for stage I non-small cell lung cancer
Slotman, Ben J.
[J]. JOURNAL OF RADIOSURGERY AND SBRT, 2011, 1 (01): : 63 - 69
[7] Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
Ze-Tian Shen
Xin-Hu Wu
Bing Li
Xi-Xu Zhu
[J]. Medical Oncology, 2015, 32
[8] Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
Shen, Ze-Tian
Wu, Xin-Hu
Li, Bing
Zhu, Xi-Xu
[J]. MEDICAL ONCOLOGY, 2015, 32 (03)
[9] Stereotactic Ablative Body Radiation Therapy for Octogenarians With Non-Small Cell Lung Cancer
Takeda, Atsuya
Sanuki, Naoko
Eriguchi, Takahisa
Kaneko, Takeshi
Morita, Satoshi
Handa, Hiroshi
Aoki, Yousuke
Oku, Yohei
Kunieda, Etsuo
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02): : 257 - 263
[10] Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer
Lagerwaard, Frank J.
Verstegen, Naomi E.
Haasbeek, Cornelis J. A.
Slotman, Ben J.
Paul, Marinus A.
Smit, Egbert F.
Senan, Suresh
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01): : 348 - 353

← 1 2 3 4 5 →